Latest Breaking News On - Chantix champix - Page 1 : comparemela.com
Pfizer - Consensus Indicates Potential - 4% Downside - DirectorsTalk Interviews
directorstalkinterviews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from directorstalkinterviews.com Daily Mail and Mail on Sunday newspapers.
Pfizer: 3 9% Dividend Yield From More Than Just The COVID-19 Vaccine
thestreet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestreet.com Daily Mail and Mail on Sunday newspapers.
Report proffers a comprehensive outlay of the Smoking Cessation Epidemiological analysis focusing on the incidence and diagnosed patient pool segmented on the basis of several factors, as well as the upcoming trends of the Smoking Cessation epidemiology that is going to impact the overall patient pool and the market outlook in the 7MM (the US, EU5 (the UK, France, Germany, Italy and Spain) and Japan).
The report covers the Smoking Cessation market trends covering key pharmaceutical companies in the market, upcoming as well as Smoking Cessation marketed therapies, unmet needs, prevailing constraints and the factors driving the market size growth.
5:04 pm
Pfizer found using ticker (PFE) now have 19 analysts in total covering the stock. The consensus rating is ‘Hold’. The target price ranges between 53 and 36 and has a mean target at 42. Now with the previous closing price of 41.12 this would indicate that there is a potential upside of 2.1%. The day 50 moving average is 37.21 and the 200 day MA is 35.19. The market capitalisation for the company is $217,945m. Company Website: http://www.pfizer.com
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also pr